FDA approves Ekterly (sebetralstat), the first oral on-demand treatment for hereditary angioedema, shown in trials to provide faster symptom relief and eliminate the need for injection.
A large Danish study found that newborns with early-onset sepsis had a higher chance of developing autism later in life, while the link to ADHD was weaker when familial factors were considered.
Newborns have higher levels of phosphorylated tau217 in their blood than even patients with Alzheimer’s disease, a new study finds, raising new questions about the dual role of tau in brain development and degeneration.
A large cohort study comparing methadone and buprenorphine for opioid use disorder found no significant difference in reducing illicit opioid use, but methadone showed better treatment retention after one year.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
A large study found that more screen time in late childhood was linked to higher depression scores in early adolescence, with shorter sleep and changes in brain white matter helping explain the connection.
A large US-based study found that people with celiac disease, hyperthyroidism, or hypothyroidism face a two- to threefold increased risk of developing type 1 diabetes, with the highest risk seen in children.
Tyzavan is the first FDA-approved vancomycin formulation available at room temperature that requires no compounding, thawing, or dilution, enabling faster treatment in time-critical infections like sepsis.